Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Montelukast (10mg) + Fexofenadine (120mg)
Therapeutic Category
Asthma, Pulmonary, Respiratory, Antihistamines
Dosage Form
Tablet
Packaging Type
Strip
Packaging
10*15
Price
₹308/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Monclip FX Tablet is a dual-action medication designed to provide effective relief from allergies and respiratory conditions. Montelukast, a leukotriene receptor antagonist, works by blocking the action of leukotrienes, substances in the body that cause airway inflammation and allergic symptoms. Fexofenadine, a non-drowsy antihistamine, alleviates symptoms like sneezing, runny nose, itchy eyes, and skin reactions by inhibiting the effects of histamine.
This combination is particularly effective for managing seasonal allergic rhinitis (hay fever), perennial allergies, and mild to moderate asthma. By targeting both inflammatory and histaminergic pathways, Monclip FX helps reduce airway constriction and nasal congestion, ensuring easier breathing and improved quality of life. It is suitable for daily use during allergy seasons or as prescribed by a healthcare provider for chronic conditions.
May cause headache, dry mouth, drowsiness (less common with Fexofenadine), abdominal pain, or fatigue. Serious side effects are rare but should be reported to a physician immediately.
Indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and other allergy-related symptoms including nasal congestion, sneezing, and itchy or watery eyes.
Use under medical supervision. Not recommended for children unless prescribed. Patients with liver or kidney impairment should consult their physician before use. Avoid alcohol and CNS depressants.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
Composition : Levocetirizine (2.5mg) + Montelukast (4mg) Bilayered
Composition : Levocetirizine (2.5mg) + Montelukast (4mg)
Composition : Fexofenadine HCL I.P. 60mg + Montelukast Sodium I.P. 4mg
Composition : Cinnarizine (25mg)
Composition : Ambroxol (15mg) + Guaifenesin (50mg) + Phenylephrine (5mg) + Paracetamol (325mg) + Cetirizine (5mg)
Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Levocetirizine (2.5mg/5ml) + Menthol (1mg/5ml)
Composition : Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Composition : Levocetirizine (10mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Montelukast Sodium 10 mg + Fexofenadine Hydrochloride 120 mg Tablet is an anti-allergic and respiratory combination medicine used for the treatment of allergic rhinitis, hay fever, sneezing, runny nose, nasal congestion, skin allergies, and asthma-related allergic symptoms. Montelukast reduces leukotriene-mediated inflammation in airways Fexofenadine is a non-sedating antihistamine that controls allergy symptoms It is a strong ENT, respiratory, and allergy-care segment product widely prescribed by physicians, ENT specialists, and pulmonologists.
Medical distributors and wholesalers can benefit from very high prescription demand throughout the year, especially in seasonal allergy periods, pollution-related respiratory issues, and urban lifestyle conditions. It is a fast-moving chronic allergy management product, ensuring stable and continuous sales.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in respiratory, anti-allergic, and ENT therapeutic segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from year-round demand, strong prescription continuity, and chronic allergy treatment usage, making it a stable, high-volume, and fast-moving pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in respiratory and anti-allergy formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the allergy and respiratory care segment.